Skip to content
Screener

CONMED CNMD Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$163.4M+1.7%
Solventum logo
SolventumSOLV
$90M+15.4%
Stryker logo
StrykerSYK
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
IAR
Integra LifeSciencesIART

Other financials

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.48B-8.8%
Enterprise value$2.46B-0.7%
P/E26.2×+11.5×
P/S1.1×-0.1×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102

Amortization expense related to intangible assets which are subject to amortization totaled $8.7 million for both the three months ended June 30, 2026 and 2025, and $17.5 million and $17.3 million for the six months ended June 30, 2026 and 2025, respectively, and is included as a reduction of revenue (for amortization related to our sales representation, marketing and

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's amortization of capitalized software and acquired intangible assets?
CONMED (CNMD) reported amortization of capitalized software and acquired intangible assets of $7.24M in Q2 2026.
How has CONMED's amortization of capitalized software and acquired intangible assets changed year-over-year?
CONMED's amortization of capitalized software and acquired intangible assets decreased by 16.8% year-over-year, from $8.7M to $7.24M.
What is the long-term trend for CONMED's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), CONMED's amortization of capitalized software and acquired intangible assets has grown at a 1.5% compound annual growth rate (CAGR), from $33.2M to $35.2M.

Ask your AI about CONMED's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude